HIV

January 11, 2024

Comprehensive Care Clinic’s Ruby Gala set for Feb. 10

The Vanderbilt Comprehensive Care Clinic, Nashville’s original nonprofit medical home for people living with HIV, will hold its annual Ruby Gala on Saturday, Feb. 10, 2024, at Marathon Music Works.

By Bill Snyder
October 25, 2023

Immune system’s role in metabolic disease detailed in tissue atlas

Researchers at Vanderbilt University Medical Center have published the largest known single-site adipose tissue atlas — a comprehensive, detailed map of the cells, structures and molecules within a specific tissue or organ, designed to support open-ended study.

By Paul Govern
February 2, 2023

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

By Bill Snyder
December 15, 2022

Dooley honored by Treatment Action Group

Vanderbilt’s Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).

By Paul Govern
November 10, 2022

Study explores CVD risk for people with HIV

A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.

By Matt Batcheldor
Luc Van Kaer, PhD, left, Luke Postoak and colleagues have identified a protein that is key to the “education” of immature T cells in the thymus.
September 1, 2022

Study identifies key player in T cell “education”

New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.

By Leigh MacMillan
March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.
By Paul Govern
February 24, 2022

Ahonkhai advances in national challenge to improve HIV care for Black men in Tennessee

A Vanderbilt proposal to implement a novel strategy to use barbers and barbershops to improve HIV care outcomes for Black men with HIV in Middle Tennessee received early-stage funding from a challenge hosted by the U.S. Department of Health and Human Services’ Office of Minority Health.
By Holly Fletcher
March 18, 2021

HIV, diabetes and immune cells in fat

In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.
By Leigh MacMillan
March 4, 2021

Clinic helps prepare young HIV patients for adult care

Adolescents and young adults living with HIV in Middle Tennessee are being ushered into adult care through a special transition clinic that focuses on adult skill-building and individualized therapy and discussions.
By Nancy Humphrey
February 18, 2021

VUMC investigator expands HIV research into South Africa

A Vanderbilt University Medical Center investigator is hoping to improve access to HIV testing in South Africa, where more than 7 million people are known to have the virus, by training traditional healers to perform the tests.
By Jake Lowary
February 8, 2021

Key factors in HIV-1 replication

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.
By Anivarya Kumar
December 10, 2020

HIV patients stay away after Nigerian clinic introduces fees

Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).
By Paul Govern
1 2 3 4